1969
DOI: 10.1016/0003-9861(69)90532-3
|View full text |Cite
|
Sign up to set email alerts
|

Tricarballylate and hydroxycitrate: Substrate and inhibitor of ATP: Citrate oxaloacetate lyase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
116
0
1

Year Published

1970
1970
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 245 publications
(119 citation statements)
references
References 21 publications
2
116
0
1
Order By: Relevance
“…ACLY converts citrate into acetyl-CoA, a precursor for fatty acid and mevalonate synthesis pathways (6)(7)(8). Both of these pathways are associated with cancer cell growth and transformation (9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
“…ACLY converts citrate into acetyl-CoA, a precursor for fatty acid and mevalonate synthesis pathways (6)(7)(8). Both of these pathways are associated with cancer cell growth and transformation (9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
“…Using a new gas chromatography-mass spectrometry technique (21), we showed that [ 13 C]oleate contributes carbon to the acetyl moiety of malonyl-CoA (16). Also, experiments with hydroxycitrate, an inhibitor of ATP-citrate lyase (22), support an at least partial role of citrate as a precursor of the acetyl moiety of malonyl-CoA in the heart (16) and in muscle (15).…”
mentioning
confidence: 98%
“…Citrate can be exported from the mitochondria via the malate-citrate shuttle system and used as a substrate for ATP-citrate lyase (ACLY) (13,27,28). ACLY catalyzes the formation of acetyl-CoA and oxaloacetate from cytosolic citrate and coenzyme A in the presence of ATP (27)(28)(29). ACLY therefore serves as a cross-link between glucose metabolism and the fatty acid and mevalonate synthetic pathways.…”
mentioning
confidence: 99%